C WorldWide Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-7,943
Closed -$128K 114
2018
Q4
$128K Sell
7,943
-204
-3% -$3.96K ﹤0.01% 120
2018
Q3
$169K Buy
8,147
+1,115
+16% +$17.5K ﹤0.01% 129
2018
Q2
$107K Hold
7,032
﹤0.01% 128
2018
Q1
$158K Sell
7,032
-222
-3% -$6.15K ﹤0.01% 122
2017
Q4
$218K Sell
7,254
-1,007
-12% -$32.2K ﹤0.01% 115
2017
Q3
$311K Buy
8,261
+1,320
+19% +$42.9K ﹤0.01% 117
2017
Q2
$194K Sell
6,941
-564
-8% -$16.8K ﹤0.01% 122
2017
Q1
$258K Sell
7,505
-679
-8% -$24K ﹤0.01% 116
2016
Q4
$236K Sell
8,184
-12,206
-60% -$323K ﹤0.01% 114
2016
Q3
$649K Hold
20,390
0.01% 114
2016
Q2
$662K Hold
20,390
0.01% 102
2016
Q1
$570K Hold
20,390
0.01% 110
2015
Q4
$727K Hold
20,390
0.01% 119
2015
Q3
$674K Sell
20,390
-69,535
-77% -$2.89M 0.01% 120
2015
Q2
$3.77M Hold
89,925
0.05% 70
2015
Q1
$2.93M Sell
89,925
-5,000
-5% -$172K 0.04% 71
2014
Q4
$3.01M Buy
+94,925
New +$2.69M 0.04% 61

Other funds holding ACAD